Marjorie B. P.
- Country
- France
- Department
- Multidisciplinary Oncology and Therapeutic Innovations Department
Research Overview
- Phase 3 Multicenter Randomized Study of Trastuzumab Deruxtecan vs. Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer Post-Trastuzumab and Taxane Treatment
- Phase III Randomized Study of Cabazitaxel and Pelvic Radiotherapy in High-Risk Localized Prostate Cancer with Androgen Deprivation Therapy
Data & Insights
Has run more than one trial at 7 of 81 partner sites.
Specializations
Gynecologic Oncology
This investigator specializes in treating advanced ovarian cancer and related conditions including primary peritoneal cancer and fallopian tube cancer. Their research explores combination therapeutic approaches using targeted treatments alongside conventional chemotherapy.
- Advanced Ovarian Cancer Management
- Combination Therapy Strategies
- Maintenance Treatment Protocols
Breast Cancer Research
The investigator focuses on treating complex breast cancer subtypes, particularly HER2-low breast cancer and hormone receptor-positive metastatic breast cancer. Their expertise extends to novel targeted therapies for advanced disease stages.
- HER2-Targeted Therapies
- Metastatic Breast Cancer Treatment
- Advanced-Stage Disease Management
Prostate Cancer Treatment
The investigator specializes in treating high-risk localized prostate cancer, implementing multi-modal treatment approaches combining hormone therapy, radiotherapy, and systemic treatments for comprehensive disease management.
- High-Risk Prostate Cancer
- Combined Modality Treatment
- Risk-Adapted Therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.